Michael Becker to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Michael Becker has written about Drug Resistance, Neoplasm.
Connection Strength
0.086
-
A phase I study of decitabine and rapamycin in relapsed/refractory AML. Leuk Res. 2013 Dec; 37(12):1622-7.
Score: 0.086
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.